Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma.
Yoko HirakiYutaka KimuraMotohiro ImanoHiroaki KatoMitsuru IwamaOsamu ShiraishiAtsushi YasudaMasayuki ShinkaiTomoki MakinoMasaaki MotooriMakoto YamasakiHiroshi MiyataTakao SatouTaroh SatohHiroshi FurukawaMasahiko YanoYuichiro DokiTakushi YasudaPublished in: Surgery today (2020)
In resectable advanced ESCC, controlling micrometastases in the LNs after NAC varied by regimen and may be associated with preventing ESCC recurrence.